Synektik Spólka Akcyjna

Warsaw Stock Exchange SNT.WA

Synektik Spólka Akcyjna Revenue Per Share for the year ending September 30, 2024

Synektik Spólka Akcyjna Revenue Per Share is NA for the year ending September 30, 2024. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • Synektik Spólka Akcyjna Revenue Per Share for the year ending September 30, 2023 was USD 11.96, a 203.33% change year over year.
  • Synektik Spólka Akcyjna Revenue Per Share for the year ending September 30, 2022 was USD 3.94, a 4.21% change year over year.
  • Synektik Spólka Akcyjna Revenue Per Share for the year ending September 30, 2021 was USD 3.78, a -0.44% change year over year.
  • Synektik Spólka Akcyjna Revenue Per Share for the year ending September 30, 2020 was USD 3.80, a -3.42% change year over year.
Key data
Date Revenue Per Share Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA)
Market news
Loading...
Warsaw Stock Exchange: SNT.WA

Synektik Spólka Akcyjna

CEO Mr. Cezary Dariusz Kozanecki
IPO Date Aug. 1, 2011
Location Poland
Headquarters ul. Józefa Piusa Dziekonskiego 3
Employees 165
Sector Health Care
Industries
Description

Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine; the development of IT solutions used in radiology; and produces and sells radiopharmaceutical products used in diagnostics for oncology. It also operates a research laboratory for diagnostic imaging systems and a service center for medical equipment. In addition, the company offers maintenance services for medical equipment, as well as acceptance and specialist tests. Synektik Spólka Akcyjna was founded in 2001 and is based in Warsaw, Poland.

Similar companies

APR.WA

Auto Partner SA

USD 4.29

2.36%

SLV.WA

Selvita S.A.

USD 11.11

-3.75%

ASB.WA

ASBISc Enterprises Plc

USD 4.27

0.06%

RVU.WA

Ryvu Therapeutics S.A.

USD 7.78

-9.75%

KRU.WA

KRUK Spólka Akcyjna

USD 103.03

2.72%

StockViz Staff

January 15, 2025

Any question? Send us an email